{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:03:59Z","timestamp":1789787039161,"version":"4.0.1"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0303"],"award-info":[{"award-number":["2023YFS0303"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013365","name":"West China Hospital, Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","award":["2018HXFH021"],"award-info":[{"award-number":["2018HXFH021"]}],"id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117924","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T04:48:32Z","timestamp":1740026912000},"page":"117924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Right ventricular dysfunction following surgical repair of tetralogy of Fallot: Molecular pathways and therapeutic prospects"],"prefix":"10.1016","volume":"184","author":[{"given":"Qiang","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2768-2410","authenticated-orcid":false,"given":"Yunfei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117924_bib1","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10741-019-09903-0","article-title":"Heart failure in adult congenital heart disease: tetralogy of Fallot","volume":"25","author":"Mueller","year":"2020","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2025.117924_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cjcpc.2023.10.009","article-title":"Tetralogy of Fallot across the lifespan: a focus on the right ventricle","volume":"2","author":"Ganni","year":"2023","journal-title":"CJC Pediatr. Congenit. Heart Dis."},{"key":"10.1016\/j.biopha.2025.117924_bib3","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/antiox10060964","article-title":"Interventricular differences of signaling pathways-mediated regulation of cardiomyocyte function in response to high oxidative stress in the post-ischemic failing rat heart","volume":"10","author":"Kov\u00e1cs","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2025.117924_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1981568","article-title":"Current knowledge and recent advances of right ventricular molecular biology and metabolism from congenital heart disease to chronic pulmonary hypertension","volume":"2018","author":"Guimaron","year":"2018","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.biopha.2025.117924_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96618-8","article-title":"Right versus left ventricular remodeling in heart failure due to chronic volume overload","volume":"11","author":"Havlenova","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib6","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.117.032285","article-title":"Renin-angiotensin-aldosterone system inhibitors for right ventricular dysfunction in tetralogy of Fallot: Quo Vadis?","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib7","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cvr\/cvx146","article-title":"Fibroblasts and the extracellular matrix in right ventricular disease","volume":"113","author":"Frangogiannis","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurasianjmed.2018.17397","article-title":"Reactive oxygen species: the dual role in physiological and pathological conditions of the human body","volume":"50","author":"Bardaweel","year":"2018","journal-title":"Eurasia J. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib9","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1038\/s41598-024-59344-5","article-title":"The relationship between cardiac oxidative stress, inflammatory cytokine response, cardiac pump function, and prognosis post-myocardial infarction","volume":"14","author":"Duan","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/mc.20465","article-title":"Molecular mechanisms of Nrf2-mediated antioxidant response","volume":"48","author":"Li","year":"2009","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.biopha.2025.117924_bib11","doi-asserted-by":"crossref","first-page":"8223","DOI":"10.3390\/ijms22158223","article-title":"Modulation of Nrf2 and NF-\u03baB signaling pathways by naturally occurring compounds in relation to cancer prevention and therapy. Are combinations better than single compounds?","volume":"22","author":"Krajka-Ku\u017aniak","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib12","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/s41598-018-38466-7","article-title":"Alfalfa polysaccharide prevents H2O2-induced oxidative damage in MEFs by activating MAPK\/Nrf2 signaling pathways and suppressing NF-\u03baB signaling pathways","volume":"9","author":"Wang","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","article-title":"NF-\u03baB in oxidative stress","volume":"7","author":"Lingappan","year":"2018","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.biopha.2025.117924_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00722","article-title":"The dark side of Nrf2 in the heart","volume":"11","author":"Zang","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117157","article-title":"MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response","volume":"241","author":"Kirk","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41598-020-80835-8","article-title":"Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease","volume":"11","author":"Saito","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1089\/ars.2013.5814","article-title":"Evolution of NADPH oxidase inhibitors: selectivity and mechanisms for target engagement","volume":"23","author":"Altenh\u00f6fer","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2025.117924_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-023-05645-y","article-title":"Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis","volume":"14","author":"Tan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2025.117924_bib19","article-title":"Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling","volume":"6","author":"Pr","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.biopha.2025.117924_bib20","article-title":"Activation of Nrf2 by miR-152 inhibits doxorubicin-induced cardiotoxicity via attenuation of oxidative stress, inflammation, and apoptosis","volume":"2021","author":"Zhang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.117924_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/253817","article-title":"The PPAR \u03b1 -PGC-1 \u03b1 Axis controls cardiac energy metabolism in healthy and diseased myocardium","volume":"2008","author":"Duncan","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.biopha.2025.117924_bib23","article-title":"AMPK: a therapeutic target of heart failure\u2014not only metabolism regulation","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib24","series-title":"Cardiomyocytes \u2013 Active Players in Cardiac Disease","first-page":"97","article-title":"Cardiac metabolism and energetic control","author":"Rohrbach","year":"2016"},{"key":"10.1016\/j.biopha.2025.117924_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MCO.0000000000000943","article-title":"The role of glucose in cardiac physiology and pathophysiology","volume":"26","author":"Mylonas","year":"2023","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.biopha.2025.117924_bib26","doi-asserted-by":"crossref","first-page":"H584","DOI":"10.1152\/ajpheart.00103.2017","article-title":"Metabolic reprogramming via PPAR\u03b1 signaling in cardiac hypertrophy and failure: From metabolomics to epigenetics","volume":"313","author":"Warren","year":"2017","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcvm.2020.00002","article-title":"Multiple levels of PGC-1\u03b1 dysregulation in heart failure","volume":"7","author":"Oka","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib28","article-title":"AMPK: a therapeutic target of heart failure\u2014not only metabolism regulation","volume":"39","author":"Li","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib29","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0303","article-title":"PPAR\u03b3 agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation","volume":"10","author":"Legchenko","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib30","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4239\/wjd.v14.i12.1862","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy probably via activating AMPK\/PGC-1\u03b1 and inhibiting the RhoA\/ROCK pathway","volume":"14","author":"Li","year":"2023","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.biopha.2025.117924_bib31","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3390\/pharmaceutics14122760","article-title":"The therapeutic strategies targeting mitochondrial metabolism in cardiovascular disease","volume":"14","author":"Huang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.117924_bib32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/ars.2017.7371","article-title":"Nanotized PPAR\u03b1 overexpression targeted to hypertrophied myocardium improves cardiac function by attenuating the p53-GSK3\u03b2-mediated mitochondrial death pathway","volume":"30","author":"Rana","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2025.117924_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib35","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.1038\/s41467-024-51791-y","article-title":"Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders","volume":"15","author":"Miotto","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117924_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1185261","article-title":"Targeting calcium regulators as therapy for heart failure: focus on the sarcoplasmic reticulum Ca-ATPase pump","volume":"10","author":"Kho","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib37","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2021.0317","article-title":"Increased SERCA2a sub-cellular heterogeneity in right-ventricular heart failure inhibits excitation-contraction coupling and modulates arrhythmogenic dynamics","volume":"377","author":"Holmes","year":"2022","journal-title":"Philos. Trans. R. Soc. B-Biol. Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib38","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2021.0317","article-title":"Increased SERCA2a sub-cellular heterogeneity in right-ventricular heart failure inhibits excitation-contraction coupling and modulates arrhythmogenic dynamics","volume":"377","author":"Holmes","year":"2022","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.biopha.2025.117924_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.734210","article-title":"RyR2 and calcium release in heart failure","volume":"12","author":"Benitah","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1134\/S1022795420070108","article-title":"Expression of the Ca2+-ATPase SERCA2a (ATP2A2) gene and the ryanodine receptor (RYR2) gene in patients with chronic heart failure","volume":"56","author":"Muslimova","year":"2020","journal-title":"Russ. J. Genet."},{"key":"10.1016\/j.biopha.2025.117924_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo1272","article-title":"Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment","volume":"8","author":"Miotto","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2025.117924_bib42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.yjmcc.2023.05.009","article-title":"RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease","volume":"181","author":"Schmeckpeper","year":"2023","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib43","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4081\/ejh.2024.4122","article-title":"Alarin regulates RyR2 and SERCA2 to improve cardiac function in heart failure with preserved ejection fraction","volume":"68","author":"Li","year":"2024","journal-title":"Eur. J. Histochem."},{"key":"10.1016\/j.biopha.2025.117924_bib44","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/eurjhf\/hfq234","article-title":"Augmentation of left ventricular mechanics by recirculation-mediated AAV2\/1-SERCA2a gene delivery in experimental heart failure","volume":"13","author":"Mariani","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2025.117924_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.122.001446","article-title":"Istaroxime and beyond: new therapeutic strategies to specifically activate SERCA and treat heart failure","volume":"384","author":"Avvisato","year":"2023","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2025.117924_bib46","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1038\/s41467-022-29703-9","article-title":"Blocking phospholamban with VHH intrabodies enhances contractility and relaxation in heart failure","volume":"13","author":"De Genst","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117924_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177130","article-title":"Intracellular delivery of a phospholamban-targeting aptamer using cardiomyocyte-internalizing aptamers","volume":"985","author":"Honda","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cjca.2013.11.009","article-title":"Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension","volume":"30","author":"Gregori","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib49","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.110.004341","article-title":"Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle","volume":"123","author":"Mital","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib50","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIR.0000000000000352","article-title":"Chronic heart failure in congenital heart disease: a scientific statement from the american heart association","volume":"133","author":"Stout","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib51","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12931-017-0679-6","article-title":"Autonomic nervous system involvement in pulmonary arterial hypertension","volume":"18","author":"Vaillancourt","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib52","doi-asserted-by":"crossref","DOI":"10.21037\/atm.2018.06.04","article-title":"Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting","volume":"6","author":"Emanuel","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12931-017-0679-6","article-title":"Autonomic nervous system involvement in pulmonary arterial hypertension","volume":"18","author":"Vaillancourt","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcha.2016.03.013","article-title":"The renin\u2013angiotensin\u2013aldosterone-system and right heart failure in congenital heart disease","volume":"11","author":"Andersen","year":"2016","journal-title":"IJC Heart Vasc."},{"key":"10.1016\/j.biopha.2025.117924_bib55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11886-012-0275-9","article-title":"Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in atherosclerosis prevention","volume":"14","author":"Patarroyo Aponte","year":"2012","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib56","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/CIRCULATIONAHA.113.001375","article-title":"Right versus left ventricular failure: differences, similarities, and interactions","volume":"129","author":"Friedberg","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib57","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/heartjnl-2020-318787","article-title":"Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle","volume":"107","author":"Ladouceur","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2025.117924_bib58","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10741-016-9566-3","article-title":"Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure","volume":"21","author":"Ameri","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2025.117924_bib59","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.117.032285","article-title":"Renin-angiotensin-aldosterone system inhibitors for right ventricular dysfunction in tetralogy of fallot: quo vadis?","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131152","article-title":"Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease","volume":"387","author":"Andi","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cjco.2023.04.004","article-title":"Design of the prospective comparison of angiotensin receptor-neprilysin inhibitor versus placebo in patients with congenital systemic right ventricle heart failure (PARACYS-RV) trial","volume":"5","author":"Chaix","year":"2023","journal-title":"CJC Open"},{"key":"10.1016\/j.biopha.2025.117924_bib62","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/bdra.20810","article-title":"Extracellular matrix and heart development","volume":"91","author":"Lockhart","year":"2011","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.biopha.2025.117924_bib63","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/ijms24021756","article-title":"Signaling pathways and potential therapeutic strategies in cardiac fibrosis","volume":"24","author":"Bertaud","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.biopha.2025.117924_bib64","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s10554-020-02117-8","article-title":"Regional shape, global function and mechanics in right ventricular volume and pressure overload conditions: a three-dimensional echocardiography study","volume":"37","author":"Bidviene","year":"2021","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"10.1016\/j.biopha.2025.117924_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96618-8","article-title":"Right versus left ventricular remodeling in heart failure due to chronic volume overload","volume":"11","author":"Havlenova","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib66","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.biopha.2016.03.033","article-title":"Liguzinediol protects against cardiac fibrosis in rats in vivo and in vitro","volume":"80","author":"Wu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2025.117924_bib67","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10741-021-10175-w","article-title":"Pirfenidone as a novel cardiac protective treatment","volume":"27","author":"Aimo","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.biopha.2025.117924_bib68","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/jcp.24367","article-title":"Acetaminophen attenuates doxorubicin-induced cardiac fibrosis via osteopontin and GATA4 regulation: reduction of oxidant levels","volume":"228","author":"Schunke","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/jiad149","article-title":"Osteopontin is an integral mediator of cardiac interstitial fibrosis in models of human immunodeficiency virus infection","volume":"228","author":"Robinson","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biopha.2025.117924_bib70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/19336918.2014.1000075","article-title":"Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy","volume":"9","author":"Franz","year":"2015","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.biopha.2025.117924_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01799","article-title":"Review on chamber-specific differences in right and left heart reactive oxygen species handling","volume":"9","author":"Schl\u00fcter","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib72","article-title":"Specific mechanisms underlying right heart failure: the missing upregulation of superoxide dismutase-2 and its decisive role in antioxidative defense","author":"Rolf","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2025.117924_bib73","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","article-title":"Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species","volume":"75","author":"Redout","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib74","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fphys.2019.01233","article-title":"Oxidative stress and its implications in the right ventricular remodeling secondary to pulmonary hypertension","volume":"10","author":"Mikhael","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.709509","article-title":"Hypoxia inducible factors as central players in the pathogenesis and pathophysiology of cardiovascular diseases","volume":"8","author":"Lucero Garc\u00eda Rojas","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib76","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/cells11142193","article-title":"NF-\u03baB p65 attenuates cardiomyocyte PGC-1\u03b1 expression in hypoxia","volume":"11","author":"Rabinovich-Nikitin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.117924_bib77","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3389\/fphar.2020.01255","article-title":"Trimetazidine ameliorates myocardial metabolic remodeling in isoproterenol-induced rats through regulating ketone body metabolism via activating AMPK and PPAR \u03b1","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib78","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1177\/1074248414524481","article-title":"The beneficial effects of ranolazine on cardiac function after myocardial infarction are greater in diabetic than in nondiabetic rats","volume":"19","author":"Mourouzis","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.117924_bib79","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ejcts\/ezw049","article-title":"Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging","volume":"50","author":"Shin","year":"2016","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.biopha.2025.117924_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamacardio.2018.4255","article-title":"Long-term outcomes of tetralogy of fallot: a study from the pediatric cardiac care consortium","volume":"4","author":"Smith","year":"2019","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib81","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1476-5381.1975.tb07422.x","article-title":"Effects of dopamine on sinus rate and ventricular contractile force of the dog heart in vitro and in vivo","volume":"55","author":"Endoh","year":"1975","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.07.003","article-title":"Dopamine outside the brain: the eye, cardiovascular system and endocrine pancreas","volume":"203","author":"Bucolo","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2025.117924_bib83","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.3390\/ijms24055042","article-title":"Role of dopamine in the heart in health and disease","volume":"24","author":"Neumann","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib84","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1007\/s00210-023-02901-y","article-title":"Initial characterization of a transgenic mouse with overexpression of the human D1-dopamine receptor in the heart","volume":"397","author":"Abella","year":"2024","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib85","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1038\/s41467-020-18128-x","article-title":"Cardiac dopamine D1 receptor triggers ventricular arrhythmia in chronic heart failure","volume":"11","author":"Yamaguchi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.117924_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2170\/physiolsci.RP003607","article-title":"Inotropic, chronotropic, and arrhythmogenic effects of dopamine on the isolated working heart of rabbit","volume":"57","author":"Wakita","year":"2007","journal-title":"J. Physiol. Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib87","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/BF02291093","article-title":"The inotropic effects of dopamine and its precursor levodopa on isolated human ventricular myocardium","volume":"63","author":"Brown","year":"1985","journal-title":"Klin. Woche"},{"key":"10.1016\/j.biopha.2025.117924_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/01.HYP.38.3.303","article-title":"Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice","volume":"38","author":"Li","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2025.117924_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074116","article-title":"The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis","volume":"8","author":"Johnson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117924_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2680.1998.1820115.x","article-title":"Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart","volume":"18","author":"Ricci","year":"1998","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib91","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00424-020-02452-8","article-title":"Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge","volume":"472","author":"Garc\u00eda-Pedraza","year":"2020","journal-title":"Pflug. Arch. - Eur. J. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib92","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.redox.2018.07.008","article-title":"Over-expression of a cardiac-specific human dopamine D5 receptor mutation in mice causes a dilated cardiomyopathy through ROS over-generation by NADPH oxidase activation and Nrf2 degradation","volume":"19","author":"Jiang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2025.117924_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003706","article-title":"Reversible treatment of pressure overload-induced left ventricular hypertrophy through Drd5 nucleic acid delivery mediated by functional polyaminoglycoside","volume":"8","author":"Jiang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib94","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/0024-3205(87)90547-9","article-title":"Catecholamine, dopamine-\u00df-hydroxylase and atrial natriuretic factor content in separate heart chambers of cardiomyopathic hamsters","volume":"41","author":"Kuchel","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2025.117924_bib95","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.925692","article-title":"\u03b2-adrenergic receptor desensitization\/down-regulation in heart failure: a friend or foe?","volume":"9","author":"Mahmood","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib96","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ppedcard.2010.11.007","article-title":"The role of \u03b2-adrenergic receptors in heart failure: differential regulation of cardiotoxicity and cardioprotection","volume":"31","author":"Bernstein","year":"2011","journal-title":"Prog. Pediatr. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib97","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/CIRCRESAHA.117.310520","article-title":"Adrenergic receptors in individual ventricular myocytes: the Beta-1 and Alpha-1B Are in all cells, the alpha-1A Is in a subpopulation, and the beta-2 and beta-3 are mostly absent","volume":"120","author":"Myagmar","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib98","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FJC.0000000000000032","article-title":"Alpha-1-adrenergic receptors in heart failure: the adaptive arm of the cardiac response to chronic catecholamine stimulation","volume":"63","author":"Jensen","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib99","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.yjmcc.2021.02.010","article-title":"Adaptation to exercise-induced stress is not dependent on cardiomyocyte \u03b11A sub adrenergic receptors","volume":"155","author":"Kaidonis","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11306-016-1097-3","article-title":"The \u03b1-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo","volume":"12","author":"Willis","year":"2016","journal-title":"Metabolomics"},{"key":"10.1016\/j.biopha.2025.117924_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168409","article-title":"An Alpha-1A adrenergic receptor agonist prevents acute doxorubicin cardiomyopathy in male mice","volume":"12","author":"Montgomery","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.117924_bib102","doi-asserted-by":"crossref","first-page":"H725","DOI":"10.1152\/ajpheart.00621.2020","article-title":"Cardiac \u03b11A-adrenergic receptors: emerging protective roles in cardiovascular diseases","volume":"320","author":"Zhang","year":"2021","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib103","doi-asserted-by":"crossref","first-page":"e519","DOI":"10.1016\/j.ijcard.2014.01.077","article-title":"An imbalance between protective and detrimental molecular pathways is associated with right ventricular dysfunction in congenital heart diseases with outflow obstruction","volume":"172","author":"Di Pietro","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib104","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI115659","article-title":"Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms","volume":"89","author":"Bristow","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2025.117924_bib105","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ejhf.253","article-title":"Sympathetic nervous system activation and \u03b2-adrenoceptor blockade in right heart failure","volume":"17","author":"Andersen","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2025.117924_bib106","doi-asserted-by":"crossref","first-page":"H888","DOI":"10.1152\/ajpheart.00042.2015","article-title":"The \u03b11A-adrenergic receptor subtype mediates increased contraction of failing right ventricular myocardium","volume":"309","author":"Cowley","year":"2015","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib107","doi-asserted-by":"crossref","first-page":"H1109","DOI":"10.1152\/ajpheart.00153.2017","article-title":"\u03b11A-Subtype adrenergic agonist therapy for the failing right ventricle","volume":"313","author":"Cowley","year":"2017","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib108","doi-asserted-by":"crossref","first-page":"H224","DOI":"10.1152\/ajpheart.00507.2018","article-title":"Reversal of right ventricular failure by chronic \u03b11A subtype adrenergic agonist therapy","volume":"316","author":"Cowley","year":"2019","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib109","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yjmcc.2023.12.003","article-title":"The alpha-1A adrenergic receptor regulates mitochondrial oxidative metabolism in the mouse heart","volume":"187","author":"Sandroni","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib110","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1172\/JCI200316100","article-title":"The \u03b11A\/C- and \u03b11B-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse","volume":"111","author":"O\u2019Connell","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2025.117924_bib111","doi-asserted-by":"crossref","first-page":"H931","DOI":"10.1152\/ajpheart.2001.281.2.H931","article-title":"Cardiac-directed overexpression of wild-type \u03b11B-adrenergic receptor induces dilated cardiomyopathy","volume":"281","author":"Lemire","year":"2001","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib112","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1139\/o04-123","article-title":"Cardiac-specific transgenic overexpression of \u03b11B-adrenergic receptors induce chronic activation of ERK MAPK signalling","volume":"82","author":"Benoit","year":"2004","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2025.117924_bib113","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCULATIONAHA.118.034271","article-title":"Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction","volume":"138","author":"Beale","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib114","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.3390\/jcm13216359","article-title":"Sex-Related differences in the pathophysiology, cardiac imaging, and clinical outcomes of aortic stenosis: a narrative review","volume":"13","author":"Dahou","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijcard.2016.11.055","article-title":"Gender differences in patients with arrhythmogenic right ventricular dysplasia\/cardiomyopathy: Clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation","volume":"227","author":"Lin","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib116","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/europace\/euab077","article-title":"Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy","volume":"23","author":"Rootwelt-Norberg","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.biopha.2025.117924_bib117","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s44161-023-00338-3","article-title":"Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension","volume":"2","author":"Khassafi","year":"2023","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00021.2015","article-title":"Mechanistic pathways of sex differences in cardiovascular disease","volume":"97","author":"Regitz-Zagrosek","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.117924_bib119","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/jbt.21417","article-title":"17\u03b2-Estradiol regulates the expression of antioxidant enzymes in myocardial cells by increasing Nrf2 translocation","volume":"26","author":"Yu","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.biopha.2025.117924_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2023.111822","article-title":"Mechanisms of mitochondrial microRNA regulation in cardiovascular diseases","volume":"212","author":"Roiz-Valle","year":"2023","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.biopha.2025.117924_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.610516","article-title":"Sex hormone regulation of proteins modulating mitochondrial metabolism, dynamics and inter-organellar cross talk in cardiovascular disease","volume":"8","author":"Lynch","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2025.117924_bib122","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1050-1738(00)00077-3","article-title":"PPAR signaling in the control of cardiac energy metabolism","volume":"10","author":"Barger","year":"2000","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib123","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cjca.2023.02.023","article-title":"Testosterone treatment impairs cardiac function and fatty acid metabolism in a rodent model of polycystic ovary syndrome","volume":"39","author":"Horkey","year":"2023","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib124","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12013-015-0521-z","article-title":"Estrogen activates AMP-activated protein kinase in human endothelial cells via ER\u03b2\/Ca2+\/calmodulin-dependent protein kinase kinase \u03b2 pathway","volume":"72","author":"Yang","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.biopha.2025.117924_bib125","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150074","article-title":"Oestrogen receptors interact with the \u03b1-catalytic subunit of AMP-activated protein kinase","volume":"35","author":"Lipovka","year":"2015","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2025.117924_bib126","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13293-021-00394-z","article-title":"Spatiotemporal AMPK\u03b12 deletion in mice induces cardiac dysfunction, fibrosis and cardiolipin remodeling associated with mitochondrial dysfunction in males only","volume":"12","author":"Grimbert","year":"2021","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.biopha.2025.117924_bib127","doi-asserted-by":"crossref","first-page":"H820","DOI":"10.1152\/ajpheart.00734.2019","article-title":"Estrogen and calcium handling proteins: new discoveries and mechanisms in cardiovascular diseases","volume":"318","author":"Jiao","year":"2020","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib128","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10741-019-09873-3","article-title":"SERCA2a: a key protein in the Ca2+ cycle of the heart failure","volume":"25","author":"Zhihao","year":"2020","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.biopha.2025.117924_bib129","doi-asserted-by":"crossref","unstructured":"Therapeutic microRNA-based strategies in cardiovascular disease discriminate sex and age difference, (n.d.). .https:\/\/doi.org\/10.1113\/JP272892.","DOI":"10.1113\/JP272892"},{"key":"10.1016\/j.biopha.2025.117924_bib130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10286-020-00720-2","article-title":"Sex differences in cardiovascular actions of the renin\u2013angiotensin system","volume":"30","author":"Medina","year":"2020","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.biopha.2025.117924_bib131","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1472-8206.2010.00854.x","article-title":"Gender and the renin\u2013angiotensin\u2013aldosterone system","volume":"24","author":"Komukai","year":"2010","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib132","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcp.2017.01.012","article-title":"Mas receptor is involved in the estrogen-receptor induced nitric oxide-dependent vasorelaxation","volume":"129","author":"Sobrino","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2025.117924_bib133","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1016\/j.mayocp.2021.08.009","article-title":"The Renin-angiotensin-aldosterone system in postmenopausal women: the promise of hormone therapy","volume":"96","author":"Gersh","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.biopha.2025.117924_bib134","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cjca.2013.11.009","article-title":"Abnormal regulation of renin angiotensin aldosterone system is associated with right ventricular dysfunction in hypertension","volume":"30","author":"Gregori","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.biopha.2025.117924_bib135","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/jcm11154280","article-title":"Sex\/gender- and age-related differences in \u03b2-adrenergic receptor signaling in cardiovascular diseases","volume":"11","author":"Liccardo","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2025.117924_bib136","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.healun.2015.10.021","article-title":"Sex-related differences in age-associated downregulation of human ventricular myocardial \u03b21-adrenergic receptors","volume":"35","author":"Lindenfeld","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.biopha.2025.117924_bib137","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12964-019-0346-2","article-title":"Estrogen regulation of cardiac cAMP-L-type Ca2+ channel pathway modulates sex differences in basal contraction and responses to \u03b22AR-mediated stress in left ventricular apical myocytes","volume":"17","author":"Machuki","year":"2019","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.biopha.2025.117924_bib138","series-title":"Sex Differences in Heart Disease","first-page":"239","article-title":"Sex-related pathophysiological differences in cardiac mitochondria: role of estrogens","author":"Pav\u00f3n","year":"2020"},{"key":"10.1016\/j.biopha.2025.117924_bib139","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8849641","article-title":"Androgen effects on the adrenergic system of the vascular, airway, and cardiac myocytes and their relevance in pathological processes","volume":"2020","author":"Carbajal-Garc\u00eda","year":"2020","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.biopha.2025.117924_bib140","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10554-020-01900-x","article-title":"Sex differences in patients with repaired tetralogy of Fallot support a tailored approach for males and females: a cardiac magnetic resonance study","volume":"36","author":"Hagdorn","year":"2020","journal-title":"Int. J. Cardiovasc Imaging"},{"key":"10.1016\/j.biopha.2025.117924_bib141","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ejcts\/ezw049","article-title":"Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging \u2020","volume":"50","author":"Shin","year":"2016","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"10.1016\/j.biopha.2025.117924_bib142","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCIMAGING.111.963637","article-title":"Impact of gender and age on cardiovascular function late after repair of tetralogy of Fallot: percentiles based on cardiac magnetic resonance","volume":"4","author":"Sarikouch","year":"2011","journal-title":"Circ. Cardiovasc Imaging"},{"key":"10.1016\/j.biopha.2025.117924_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.623129","article-title":"Sex differences in right ventricular dysfunction: insights from the bench to bedside","volume":"11","author":"Keen","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2025.117924_bib144","doi-asserted-by":"crossref","unstructured":"L. Harbaum, J.K. Hennigs, J. Pott, J. Ostermann, C.R. Sinning, A. Sau, E. Sieliwonczyk, F.S. Ng, C.J. Rhodes, K. Tello, H. Klose, S. Gr\u00e4f, M.R. Wilkins, Sex-specific genetic determinants of right ventricular structure and function, 2024, 2024.02.06.23300256. https:\/\/doi.org\/10.1101\/2024.02.06.23300256.","DOI":"10.1101\/2024.02.06.23300256"},{"key":"10.1016\/j.biopha.2025.117924_bib145","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab724.1875","article-title":"Pulmonary valve replacement in women with repaired tetralogy of Fallot. Contrasting indications compared with men","volume":"42","author":"Ladron","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2025.117924_bib146","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00310","article-title":"The Role of 17\u03b2-estradiol and estrogen receptors in regulation of Ca2+ channels and mitochondrial function in cardiomyocytes","volume":"10","author":"Mahmoodzadeh","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2025.117924_bib147","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001738","article-title":"Long-term follow-up and sex differences in adults operated for tetralogy of Fallot","volume":"8","author":"Quattrone","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.biopha.2025.117924_bib148","doi-asserted-by":"crossref","first-page":"10549","DOI":"10.3390\/ijerph181910549","article-title":"Risk factors of right ventricular dysfunction and adverse cardiac events in patients with repaired tetralogy of fallot","volume":"18","author":"Leonardi","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.biopha.2025.117924_bib149","series-title":"Congenital Heart Diseases: The Broken Heart: Clinical Features, Human Genetics and Molecular Pathways","first-page":"617","article-title":"Clinical presentation and therapy of tetralogy of fallot and double-outlet right ventricle","author":"Haas","year":"2024"},{"key":"10.1016\/j.biopha.2025.117924_bib150","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001738","article-title":"Long-term follow-up and sex differences in adults operated for tetralogy of Fallot","volume":"8","author":"Quattrone","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.biopha.2025.117924_bib151","article-title":"Pulmonary valve replacement timing following initial tetralogy of fallot repair: a systematic review","volume":"15","author":"Slouha","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.biopha.2025.117924_bib152","doi-asserted-by":"crossref","first-page":"ii208","DOI":"10.1093\/eurheartjsupp\/suae036.498","article-title":"Gender differences on clinical outcomes in patients undergoing transcatheter pulmonary valve implantation","volume":"26","author":"Marzullo","year":"2024","journal-title":"Eur. Heart J. Suppl."},{"key":"10.1016\/j.biopha.2025.117924_bib153","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.3390\/jcm12227020","article-title":"Arrhythmias in patients with congenital heart disease: an ongoing morbidity","volume":"12","author":"Ntiloudi","year":"2023","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.biopha.2025.117924_bib154","first-page":"1304","article-title":"Sex differences in outcomes of tetralogy of fallot patients with implantable cardioverter-defibrillators","volume":"8","author":"Waldmann","year":"2022","journal-title":"JACC: Clin. Electrophysiol."},{"key":"10.1016\/j.biopha.2025.117924_bib155","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.122.062021","article-title":"Assessment of cardiac energy metabolism, function, and physiology in patients with heart failure taking empagliflozin: the randomized, controlled EMPA-VISION trial","author":"Hundertmark","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2025.117924_bib156","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","volume":"15","author":"Jaski","year":"2009","journal-title":"J. Card. Fail"},{"key":"10.1016\/j.biopha.2025.117924_bib157","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/ejhf.826","article-title":"Effect of intracoronary administration of AAV1\/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial","volume":"19","author":"Hulot","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2025.117924_bib158","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(16)00082-9","article-title":"Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial","volume":"387","author":"Greenberg","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.117924_bib159","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41434-020-0171-7","article-title":"Investigation of the safety and feasibility of AAV1\/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL","volume":"27","author":"Lyon","year":"2020","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2025.117924_bib160","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1097\/JS9.0000000000001074","article-title":"Advancements and mechanisms of stem cell-based therapies for spinal cord injury in animals","volume":"110","author":"Mili","year":"2024","journal-title":"Int. J. Surg."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:46:22Z","timestamp":1741045582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":160,"alternative-id":["S0753332225001180"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117924","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Right ventricular dysfunction following surgical repair of tetralogy of Fallot: Molecular pathways and therapeutic prospects","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117924","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117924"}}